As a Development Asset Lead (DAL), you will be at the forefront of our portfolio, serving as a full-time leader for one or more preclinical or clinical stage assets within Development. Your role is integral in providing strategic, multi-disciplinary drug development expertise to maximize asset value and delivery. Leading the asset team, you will drive the development and execution of an Integrated Asset Plan (IAP), managing associated budgets and resources efficiently. This position requires seamless collaboration across functions, ensuring all voices are heard and integrating business considerations of time, risk, and value into planning and execution. You will be accountable to governance mechanisms for asset-related actions and decisions, representing the asset at portfolio forums and engaging with senior stakeholders. By defining clear asset goals aligned with the IAP, you'll ensure projects are effectively managed and resources strategically applied, fostering a healthy and effective team environment. Your partnership with the Program Manager will be key to executing the IAP effectively and timely.
You are a strategic thinker with a robust understanding of drug development processes. Your ability to lead with influence in a matrixed environment is unmatched, and you naturally foster collaboration across teams. You excel in communication, adapting your style to suit various audiences, and possess a keen sense of empathy and authenticity. Your executive presence is evident as you navigate senior stakeholder interactions with confidence. With a servant leadership mindset, you motivate teams to achieve challenging goals while maintaining a resilient approach to changing circumstances.
Biogen is a leading biotech company focused on neurological diseases, developing innovative medicines, biologics, small molecules, and biosimilars.
View company profile →